*ST Matilda announced that the company's subsidiary Guangdong Mingzhi Medical Testing Laboratory Co., Ltd. participated in the investment of the Wuhan Optics Valley Cornerstone Investment Fund partnership with its own capital of 20 million yuan. Recently, Cornerstone Fund has completed industrial and commercial registration procedures and obtained a business license issued by the Wuhan Municipal Administration of Market Supervision. The fund has invested 100 billion yuan. The date of establishment is September 18, 2026. As of the date of disclosure of the announcement, the fund still needs to be registered by the China Securities Investment Fund Industry Association, and there is uncertainty about subsequent implementation.

*ST Matilda announced that the company's subsidiary Guangdong Mingzhi Medical Testing Laboratory Co., Ltd. participated in the investment of the Wuhan Optics Valley Cornerstone Investment Fund partnership with its own capital of 20 million yuan. Recently, Cornerstone Fund has completed industrial and commercial registration procedures and obtained a business license issued by the Wuhan Municipal Administration of Market Supervision. The fund has invested 100 billion yuan. The date of establishment is September 18, 2026. As of the date of disclosure of the announcement, the fund still needs to be registered by the China Securities Investment Fund Industry Association, and there is uncertainty about subsequent implementation.